92%
of patients treated saw at least half of their inflammatory acne resolved at 12 months after their final treatment session.1
9/10
of patients were “satisfied” or “very satisfied” after treatment.2
3/4
of patients were “likely” or “very likely” to have laser treatment again if needed.3
Hear from AviClear Patients
Patient Reviews
A Physician’s Take on AviClear
R. Sonia Batra, MD, MSc, MPH
Board-Certified Dermatologist
“Patients are excited about this treatment because it does not involve systemic medications, possible medication side effects, or blood test monitoring.”
“Patients also like that it is a finite protocol of three treatments one month apart that they are scheduled to have performed rather than a regimen they must continue on their own for an open-ended length of time – months or even years.”
- Data on File, Cutera, Inc.
- Goldberg D, et al. Selective photothermolysis with a novel 1726 nm laser beam: A safe and effective solution for acne vulgaris. J Cosmet Dermatol. 2023;22(2):486-496. doi:10.1111/jocd.15602
- Alexiades M, et al. Novel 1726 nm laser demonstrates durable therapeutic outcomes and tolerability for moderate-to-severe acne across skin types. J Am Acad Dermatol. 2023;89(4):703-710. doi:10.1016/j.jaad.2023.05.085.









